Announcements Trials
Browse Landscape

Phase

Phase 3 4

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Leiomyoma 4Menorrhagia 2

Interventions

telapristone acetate 18vilaprisan 12relugolix 11estradiol, norethindrone drug combination 9asoprisnil 9Estradiol 8elagolix 7Uterine Myomectomy 7ulipristal acetate 6Norethindrone Acetate 6Leuprolide 5linzagolix 4Uterine Artery Embolization 3Sugars 3ulipristal 2Progestins 2Mifepristone 2epigallocatechin gallate 1carbetocin 1Vitamin D 1Vitamin B 6 1Therapeutics 1Standard of Care 1Sodium Chloride 1Robotic Surgical Procedures 1Radiofrequency Ablation 1Progesterone 1Microbial Collagenase 1Megestrol Acetate 1Medroxyprogesterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Leiomyoma × linzagolix × Clear all
NCT05445167 2025-11-25

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
89 enrolled

Leiomyoma

NCT05440383 2025-03-14

A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia

Kissei Pharmaceutical Co., Ltd.

Phase 3 Completed
287 enrolled

Leiomyoma

NCT03070899 2021-06-09

PRIMROSE 1

ObsEva SA

Phase 3 Completed
526 enrolled

Leiomyoma, Menorrhagia

NCT03070951 2021-03-05

PRIMROSE 2

ObsEva SA

Phase 3 Completed
511 enrolled

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡